Pluristyx to lead a new public-private consortium with 9 other industry leaders to establish global standards for non-animal drug testing models ...

Pluristyx to lead a new public-private consortium with 9 other industry leaders to establish global standards for non-animal drug testing models ...

“By accelerating the production and sharing of trustworthy data, as we are doing at MassCPR, we can empower the public with ...

“This means a doctor gains a much clearer picture of the tumour – its molecular profile, morphology, and likely response to treatment,” Čekan explained. “Most current tests analyse only a few markers ...

Amylyx Pharmaceuticals, Inc. ("Amylyx" or the "Company") today announced the presentation of early safety and tolerability data from its Phase 1 LUMINA trial of AMX0114 and results from ongoing work ...

Citi Annual Global Healthcare Conference 2025 December 2, 2025 2:30 PM ESTCompany ParticipantsSteven Harr - President, ...

Grist reports that Arizona's fight against coccidioidomycosis (valley fever) faces challenges due to climate change and Trump ...

The same mRNA technology used in COVID-19 vaccines may offer a powerful new way to prevent long-term muscle damage caused by ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

The FDA estimates that a typical non-clinical programme with a monoclonal antibody product could include more than 100 NHPs, ...

Monkeys have been test subjects for infectious diseases for decades. However, that will soon come to an end, according to the ...

The FDA encourages sponsors to discuss plans to use animal testing alternatives, called new approach methodologies or NAMs, ...